ATE330625T1 - Enzymatische behandlung von retinitis pigmentosa und pharmazeutische zusammensetzung hierfür in form eines kits - Google Patents

Enzymatische behandlung von retinitis pigmentosa und pharmazeutische zusammensetzung hierfür in form eines kits

Info

Publication number
ATE330625T1
ATE330625T1 AT02785892T AT02785892T ATE330625T1 AT E330625 T1 ATE330625 T1 AT E330625T1 AT 02785892 T AT02785892 T AT 02785892T AT 02785892 T AT02785892 T AT 02785892T AT E330625 T1 ATE330625 T1 AT E330625T1
Authority
AT
Austria
Prior art keywords
kit
pharmaceutical composition
retinitis pigmentosa
enzymatic treatment
enzymes
Prior art date
Application number
AT02785892T
Other languages
English (en)
Inventor
Paola Ammannati
Roberto Giordani
Original Assignee
Paola Ammannati
Roberto Giordani
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paola Ammannati, Roberto Giordani filed Critical Paola Ammannati
Application granted granted Critical
Publication of ATE330625T1 publication Critical patent/ATE330625T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/443—Oxidoreductases (1) acting on CH-OH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4813—Exopeptidases (3.4.11. to 3.4.19)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
    • C12Y101/01021—Aldehyde reductase (1.1.1.21), i.e. aldose-reductase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
    • C12Y101/01049—Glucose-6-phosphate dehydrogenase (1.1.1.49)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y111/00—Oxidoreductases acting on a peroxide as acceptor (1.11)
    • C12Y111/01—Peroxidases (1.11.1)
    • C12Y111/01009—Glutathione peroxidase (1.11.1.9)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/13—Dipeptidases (3.4.13)
    • C12Y304/13009—Xaa-Pro dipeptidase (3.4.13.9) i.e. prolidase

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
AT02785892T 2002-10-01 2002-10-01 Enzymatische behandlung von retinitis pigmentosa und pharmazeutische zusammensetzung hierfür in form eines kits ATE330625T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IT2002/000624 WO2004030693A1 (en) 2002-10-01 2002-10-01 Enzymatic treatment of retinitis pigmentosa and relevant pharmaceutical composition in form of a kit

Publications (1)

Publication Number Publication Date
ATE330625T1 true ATE330625T1 (de) 2006-07-15

Family

ID=32051201

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02785892T ATE330625T1 (de) 2002-10-01 2002-10-01 Enzymatische behandlung von retinitis pigmentosa und pharmazeutische zusammensetzung hierfür in form eines kits

Country Status (12)

Country Link
US (1) US7445777B2 (de)
EP (1) EP1545590B1 (de)
JP (1) JP2006504715A (de)
CN (1) CN1321691C (de)
AT (1) ATE330625T1 (de)
AU (1) AU2002349813A1 (de)
BR (1) BR0215896A (de)
CA (1) CA2500068A1 (de)
DE (1) DE60212729T2 (de)
ES (1) ES2266601T3 (de)
NZ (1) NZ538969A (de)
WO (1) WO2004030693A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1753444A1 (de) * 2004-06-08 2007-02-21 Paola Ammannati Enzymatische behandlung von retinitis pigmentosa und relevante pharmazeutische zusammensetzung dafür in form eines sets
US20110021974A1 (en) * 2010-10-05 2011-01-27 Shantha Totada R Retinitis pigmentosa treatment and prophalaxis
US10155028B2 (en) 2013-08-26 2018-12-18 Health Research, Inc. Method for prophylaxis and/or treatment of ErbB2 positive cancers
US10478477B2 (en) 2014-08-20 2019-11-19 Health Research, Inc. Method for prophylaxis or treatment of erbb1 positive cancers using a variant peptidase d with reduced activity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2784030B1 (fr) * 1998-10-02 2002-12-20 Inst Nat Sante Rech Med Utilisation de bloqueurs des canaux calciques et/ou cgmp-dependants pour le traitement de pathologies de la retine
FR2784898A1 (fr) * 1998-10-26 2000-04-28 Univ Pasteur Utilisation du gdnf pour le traitement de la degenerescence retinienne

Also Published As

Publication number Publication date
DE60212729D1 (de) 2006-08-03
BR0215896A (pt) 2005-08-09
CN1321691C (zh) 2007-06-20
CN1671411A (zh) 2005-09-21
DE60212729T2 (de) 2007-06-28
US7445777B2 (en) 2008-11-04
AU2002349813A1 (en) 2004-04-23
JP2006504715A (ja) 2006-02-09
US20060134088A1 (en) 2006-06-22
CA2500068A1 (en) 2004-04-15
NZ538969A (en) 2006-06-30
WO2004030693A1 (en) 2004-04-15
EP1545590B1 (de) 2006-06-21
EP1545590A1 (de) 2005-06-29
ES2266601T3 (es) 2007-03-01

Similar Documents

Publication Publication Date Title
WO2005016227A3 (en) Methods and pharmaceutical compositions for modulating heparanase activation and uses thereof
GEP20094666B (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
WO2007067504A3 (en) Lactam compounds and methods of using the same
WO2005082341A3 (en) NON-PEPTIDYL AGENTS WITH pHSP20-LIKE ACTIVITY, AND USES THEREOF
GB2393202A (en) Methods of well treatment
WO2004010937A3 (en) Method of treating cancer
MXPA05006629A (es) Formas de dosificacion que contienen un inhibidor de bomba de protones, un nsaid y un amortiguador.
WO2004089296A3 (en) Improved inhibitors for the soluble epoxide hydrolase
MY134480A (en) 4-pyrrolidino-phenyl-benzyl ether derivatives
BRPI0307349B8 (pt) processo para fermentar uma composição de fitoesterol
WO2007061939A3 (en) Metabolite derivatives of the hdac inhibitor fk228
WO2007097806A3 (en) Self-improvement system and method
AU2003233172A1 (en) Methods compositions and articles of manufacture for modulating bone growth
WO2002004409A3 (en) Tetrahydrobenzothiazole analogues as neuroprotective agents
WO2003066597A3 (en) Guanidino compounds
MY130792A (en) 17ß-HYDROXYSTEROID DEHYDROGENASE TYPE 3 INHIBITORS FOR THE TREATMENT OF ANDROGEN DEPENDENT DISEASES
ATE330625T1 (de) Enzymatische behandlung von retinitis pigmentosa und pharmazeutische zusammensetzung hierfür in form eines kits
WO2004053078A3 (en) METHODS FOR MODULATING IKKα ACTIVITY
PT1441708E (pt) Composições e métodos para aumentar a observância de terapias utilizando inibidores da aldeído desidrogenase e para tratar alcoolismo
WO2004044000A3 (en) Compounds and methods for modulating functions of classical cadherins
NO20073610L (no) Nye substituerte tiofenpyrimidinonderivater som inhibitorer for 17 β-hydroksysteroiddehydrogenase
AU2003206926A1 (en) Cultivation method for micro-organisms and bioreactor
AU2002232127A1 (en) Method for the processing of leather
WO2004048597A3 (en) Composition and method for inhibition of microorganisms
WO2003039331A3 (en) Method for improving stability of a bone-connecting implant

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1545590

Country of ref document: EP

REN Ceased due to non-payment of the annual fee